Tom C. Thomas - 22 Dec 2021 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Reporting relationship: General Counsel and Chief Legal Officer
Issuer ticker: VINC
Reported as of: 22 Dec 2021
Net transaction value: +$10,230
SEC form: 4
Accepted by SEC: 27 Dec 2021, 15:48:19 UTC
Prior SEC filing: 30 Jun 2021
Next SEC filing: 16 Feb 2022
Source filing: View source filing
Reporting owner signature: By: /s/ Tom C. Thomas

Key filing fact

Tom C. Thomas filed Form 4 for Vincerx Pharma, Inc. (VINC) on 27 Dec 2021.

Key facts

This page summarizes Tom C. Thomas's Form 4 filing for Vincerx Pharma, Inc. (VINC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Dec 2021, 15:48.

Change

Previous filing in this sequence was filed on 30 Jun 2021.
Current net transaction value: +$10,230.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VINC transaction

Common Stock

Purchase

Transaction value: $10,230
Shares: +1,000
Change %: +50%
Price: $10.23
Shares after: 3,000
Date: 22 Dec 2021
Ownership: The Thomas Family Revocable Trust, dated 9/11/2012

VINC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 206,939
Date: 22 Dec 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 1,417 shares of common stock acquired under the Vincerx Pharma, Inc. 2021 Employee Stock Purchase Plan on November 12, 2021.

SEC remarks

General Counsel and Chief Legal Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .